Zimmer Biomet reports that most product lines impacted by previously disclosed shipping delays have returned to full shipping capacity, and disclosed the receipt of a Form 483 following an FDA inspection of a legacy Biomet manufacturing site in Warsaw, Indiana.
No patient safety concerns have been identified with products manufactured at the site.
Sources: Zimmer Biomet, Inc.; ORTHOWORLD Inc.